|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K2039/507 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K2317/622 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 48/00 | (2013.01) | ||
| C07K 14/70503 | (2013.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C12N2740/10043 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3313883 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16736667.3 |
| Date of filing the European patent application | 2016-06-23 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/039015 |
| Date | 2016-06-23 |
| (87) | Number | WO 2016/210129 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 201562183297 P | 2015-06-23 | US | |
| 201562266398 P | 2015-12-11 | US |
| (72) |
BRENTJENS, Renier J. , US
JACKSON, Hollie Jaine , AU
LIU, Cheng , US
|
| (73) |
Memorial Sloan Kettering Cancer Center ,
1275 York Avenue, New York, NY 10065,
US
Eureka Therapeutics, Inc. , 5858 Horton Street, Suite 370, Emeryville, CA 94608, US |
| (54) | NOVEL PD-1 IMMUNE MODULATING AGENTS |
| NOVEL PD-1 IMMUNE MODULATING AGENTS |